Chaitra Universal Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 64.07%
(FY 2020)
- Profit 24.28%
(FY 2020)
- Ebitda 14.50%
(FY 2020)
- Net Worth 37.51%
(FY 2020)
- Total Assets 33.80%
(FY 2020)
About Chaitra Universal Formulations
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Laxmi Badarla and Trinadha Badarla serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PTC094621
- Company No.
094621
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chaitra Universal Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmi Badarla  | Director | 25-Jun-2014 | Current |
| Trinadha Badarla | Director | 25-Jun-2014 | Current |
Financial Performance and Corporate Structure Insights of Chaitra Universal Formulations.
Chaitra Universal Formulations Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 64.07% increase. The company also saw a substantial improvement in profitability, with a 24.28% increase in profit. The company's net worth Soared by an impressive increase of 37.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chaitra Universal Formulations?
In 2020, Chaitra Universal Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rikvin Biotech Private LimitedActive 7 years 7 monthsLaxmi Badarla and Trinadha Badarla are mutual person
Rikvin Greentech India Private LimitedActive 6 years 2 daysLaxmi Badarla and Trinadha Badarla are mutual person
- Rainbow Healthcare Products Private LimitedActive 1 year 4 months
Laxmi Badarla and Trinadha Badarla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chaitra Universal Formulations?
Unlock and access historical data on people associated with Chaitra Universal Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chaitra Universal Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chaitra Universal Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
